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Kawasaki disease (KD) is an acute febrile illness of early childhood. Previous reports
have suggested that genetic disease susceptibility factors, together with a triggering
infectious agent, could be involved in KD pathogenesis; however, the precise etiology
of this disease remains unknown. Additionally, previous culture-based studies have
suggested a possible role of intestinal microbiota in KD pathogenesis. In this study, we
performed metagenomic analysis to comprehensively assess the longitudinal variation
in the intestinal microbiota of 28KD patients. Several notable bacterial genera were
commonly extracted during the acute phase, whereas a relative increase in the number
of Ruminococcus bacteria was observed during the non-acute phase of KD. The
metagenomic analysis results based on bacterial species classification suggested that
the number of sequencing reads with similarity to five Streptococcus spp. (S. pneumonia,
pseudopneumoniae, oralis, gordonii, and sanguinis), in addition to patient-derived
Streptococcus isolates, markedly increased during the acute phase in most patients.
Streptococci include a variety of pathogenic bacteria and probiotic bacteria that promote
human health; therefore, this further species discrimination could comprehensively
illuminate the KD-associated microbiota. The findings of this study suggest that
KD-related Streptococci might be involved in the pathogenesis of this disease.
Keywords: Kawasaki disease, gut microbiota, metagenomic analysis, Streptococcus, mitis group
Introduction
Kawasaki disease (KD) is an acute febrile illness of early childhood. The principal pathology is
systemic vasculitis with coronary artery involvement, and KD is the leading cause of acquired
heart disease in developed countries. It was originally described by Dr. Tomisaku Kawasaki in
1967 (Kawasaki, 1967), and it is known to occur worldwide in children of all races. However,
as the etiology of KD remains unknown, no specific biological markers for diagnostic testing
Abbreviations: BLAST, Basic Local Alignment Search Tool; BWA-SW, Burrows-Wheeler Aligner’s Smith-Waterman
Alignment; CFU, colony forming unit; EDTA, ethylenediaminetetraacetic acid; FASTQ, a text-based format for storing
both a biological sequence (usually a nucleotide sequence) and its corresponding quality scores; KD, Kawasaki disease;
LPS, lipopolysaccharide; LEfSe, linear discriminant analysis (LDA) coupled with effect size measurements; LDA, linear
discriminant analysis; MEGAN, MEtaGenome Analyzer; PCA, Principal component analysis; PERMANOVA, Permutational
Multivariate Analysis Of Variance; TCR, T-cell receptor.
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have been characterized to date. The diagnosis of KD is based
on the following six clinical features: fever lasting for at least
5 days, changes in the extremities, polymorphous exanthem,
bilateral conjunctival injection without exudate, changes in the
lips and oral cavity, and cervical lymphadenopathy (Newburger
et al., 2004). Although the simultaneous intravenous infusion
of gamma globulin and aspirin is effective in reducing systemic
inflammation and preventing coronary artery involvement,
coronary abnormalities still develop in ∼5% of affected children,
and some patients show no response to this therapy (Newburger
et al., 1991).
The annual incidence of KD is increasing rapidly in Japan,
with 239.6/100,000 children under the age of 5 years affected
in 2010. This incidence is by far the highest rate worldwide
(Nakamura et al., 2012), and the risk of KD in siblings of
affected children is significantly higher than that in the general
population (Fujita et al., 1989). The annual incidence rates
are also relatively high in other East Asian countries (with
113.1/100,000 children under the age of 5 years affected in Korea
and 69/100,000 in Taiwan) but are low in Europe and North
America (with 4.9–15.2/100,000 children under the age of 5
years affected in European countries and 19–26.2/100,000 in
North American countries) (Uehara and Belay, 2012). A higher
rate of KD has been reported in Hawaiian children of Japanese
descent compared with those of European descent (Holman et al.,
2010), suggesting the importance of genetic factors in disease
susceptibility.
Epidemiological studies have shown that the age-specific
incidence rate of KD is the highest among children aged 6–
11 months and that 88.4% of KD patients are less than 1
year of age (Uehara and Belay, 2012). Interestingly, a seasonal
variation in the number of affected KD patients has been
observed (Nakamura et al., 2008). These findings suggest
that an infectious agent may trigger this disease; however,
its etiology remains unknown. A GWAS of KD in Japanese
patients has revealed susceptibility loci related to immune
disorders and a human leukocyte antigen; such extensive
studies will facilitate characterization of the pathogenesis and
pathophysiology (Onouchi, 2012; Onouchi et al., 2012).
Previous reports have suggested that an elevation in
lipopolysaccharide (LPS, endotoxin)-binding neutrophils or
plasma proteins (Takeshita et al., 1999, 2002b), antibody
reactivity against mycobacterial heat-shock protein (HSP65)
in convalescent sera (Yokota et al., 1993), and unique TCR
Vβ expansion by certain superantigens (SAg) in KD patients
(Abe et al., 1992; Yoshioka et al., 1999) might be involved
in KD pathogenesis. Case reports have suggested that these
factors are attributed to the presence of secondary infections
with various pathogens, including Streptococcus pyogenes,
Staphylococcus aureus, Mycoplasma pneumoniae, Chlamydia
pneumoniae, Klebsiella pneumoniae, adenovirus, Epstein-
Barr virus, parvovirus B19, herpesvirus 6, parainfluenza
virus, measles, rotavirus, dengue virus, varicella zoster virus,
cytomegalovirus, and influenza virus (Johnson and Azimi,
1985; Catalano-Pons et al., 2005; Wang et al., 2005; Joshi
et al., 2011; Principi et al., 2013). In animal models, exposure
to the Lactobacillus bacterial cell wall (Duong et al., 2003),
immunization with bacillus Calmette-Guérin (BCG) (Nakamura
et al., 2007), or exposure to the Candida albicans water-soluble
fraction (Nagi-Miura et al., 2004; Ohno, 2004) has been shown
to induce vasculitis and coronary arteritis. These observations
further suggest that infectious agents promote the onset of KD.
The intestinal microbiota constitutes a vast ecosystem with a
crucial role in establishing the mucosal immune system, and the
intestinal microbiota of healthy adults is considered to be inter-
individually variable and intra-individually stable over long time
periods (Eckburg et al., 2005; Jakobsson et al., 2010; Arumugam
et al., 2011; Jalanka-Tuovinen et al., 2011). By contrast, the
intestinal microbiota of infants is different from that of adults,
with intestinal microbiota succession being affected by breast
or formula feeding, weaning, diet, and unexpected life events,
including infection and antibiotic treatment (Stark and Lee,
1982; Palmer et al., 2007; De Filippo et al., 2010; Koenig et al.,
2011; Morotomi et al., 2011). The pathogenesis of KD has been
suggested to involve a hyperimmune reaction in children who
are genetically susceptible to variations in the normal flora; these
variations are induced by environmental factors (Lee et al., 2007).
The intestinal microbiota of KD patients is characterized by
a lack of Lactobacilli during the acute phase (Takeshita et al.,
2002a) and the presence of HSP60-producing Gram-negative
microbes (genera Acinetobacter, Enterobacter, Neisseria, and
Veillonella) and Gram-positive cocci (genera Streptococcus and
Staphylococcus) with the ability to induce Vβ2 T cell expansion
(Nagata et al., 2009). However, these studies on the intestinal
profiles of KD patients were performed using culture-based
methods.
Metagenomic analyses can reveal both the bacterial and viral
compositions of the intestinal microbiota; thus, metagenomics
can be used to identify potential pathogens in infectious
diseases of unknown etiology (Kuroda et al., 2012). For
instance, a metagenomic approach has revealed the presence of
Streptococcus spp. in lymph node specimens of a KD patient,
highlighting the possible role of these bacteria in KD (Katano
et al., 2012).
In this study, a comparative metagenomic approach was
used to characterize the differential microbiota compositions
of KD patients by studying individual clinical specimens in
a longitudinal manner. No study to date has performed
longitudinal analysis of the microbial microbiota compositions
of KD patients using a metagenomic approach. Indeed, although
previous studies have suggested a possible role of the intestinal
microbiota in the pathogenesis of KD, they have relied only
on culture-based methods for microbial detection (Takeshita
et al., 2002a; Nagata et al., 2009). We therefore performed
metagenomic analysis using a non-culture-based method to
expand upon these results.
Materials and Methods
Clinical Specimens Used for Comparative
Metagenomic Analysis
For the KD patient group, fecal samples were obtained at the
time of admission (the acute phase), at the time of discharge
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(the convalescent phase), and at 4–6 months after the onset of
KD (the non-acute phase). The study protocol was approved by
the institutional medical ethics committee of the University of
Tokyo, Tokyo Women’s Medical University and the National
Institute of Infectious Diseases in Japan (Approval No. 295),
and it was conducted according to the Declaration of Helsinki
Principles. Written informed consent was obtained from the
parents of all children for publication of their individual details
and accompanying images in this manuscript. The consent form
is held by the authors’ institution and is available for review.
DNA Extraction from Fecal Samples
Total DNA extraction was performed using a QIAamp R© DNA
Stool Mini Kit (QIAGEN, Tokyo, Japan) according to the
manufacturer’s instructions. To increase the recovery of bacterial
DNA, particularly from Gram-positive bacteria, pretreatment
with lytic enzymes was performed prior to extraction using the
stool kit. Briefly, 100mg of fecal sample was suspended in 10mL
of Tris-EDTA buffer (pH 7.5), and 50µL of 100mg/mL lysozyme
type VI purified from chicken egg white (MPBIO, Derby, UK)
and 50µL of 1mg/mL purified achromopeptidase (Wako, Osaka,
Japan) were added. The solution was incubated at 37◦C for 1 h
withmixing, 0.12 g of sodium dodecyl sulfate (final conc. 1%) was
added, and the suspension was mixed until it became clear. Next,
100µL of 20mg/mL proteinase K (Wako) was added, followed by
incubation at 55◦C for 1 h with mixing. The cell lysate was then
subjected to ethanol precipitation. The precipitant was dissolved
in 1.6mL of ASL buffer from the stool kit and subsequently
purified using a QIAamp R© DNA Stool Mini Kit (QIAGEN).
DNA Library Preparation for Metagenomic
Analysis and Short-read DNA Sequencing
A DNA library was prepared using a Nextera™ DNA Sample
Prep Kit (Illumina-compatible, EPICENTRE Biotechnologies,
Madison, WI, USA), and DNA clusters were generated on
a slide using a Cluster Generation Kit (version 2) with
an Illumina cluster station (Illumina, San Diego, CA, USA)
according to the manufacturer’s instructions. The general
procedure described in the standard protocol (Illumina)
was performed to obtain standard ∼1.0 × 107 short reads
for 1 lane. All of the sequencing runs for generating
126-mers were performed with a Genome Analyzer IIx
using an Illumina Sequencing Kit (http://www.illumina.com/
systems/retired_gaiix/gaiix-kits.html). Fluorescence images were
analyzed using Illumina base-calling pipeline (version 1.4.0)
to obtain FASTQ-formatted sequence data. The short-read
sequences have been deposited in DNA Data Bank of Japan
(DDBJ; accession numbers: DRA000895 and DRA001171). All
of the obtained DNA sequencing reads were aligned to a
reference human genomic sequence using BWA-SW read-
mapping software (Li and Durbin, 2010), with quality trimming
to remove low-quality reads. The remaining sequence reads were
subjected to a megaBLAST search against a nucleotide database.
The results of this search were analyzed and visualized using
MEGAN version 4.62.3 (Huson et al., 2011), with a minimum
support of 1 hit and a minimum score of 150.
Principal Component Analysis (PCA) and
PERMANOVA Analysis
The sequenced reads were assigned to a taxonomic hierarchy
using MEGAN software following a megaBLAST homology
search. The raw read counts were normalized by the total number
of reads, and then PCA was performed using the R “prcomp” and
“plot” functions. Permutational multivariate analysis of variance
(PERMANOVA) with “ADONIS” was performed using 10,000×
permutations and the “bray” method with R’s vegan package
(Anderson, 2001).
Linear Discriminant Analysis (LDA) Coupled With
Effect Size Measurements (LEfSe)
A metagenomic biomarker discovery approach, LEfSe, was used
to identify the microbial components whose sequences were
more abundant in the fecal samples of the KD patients during
the acute phase than in those of the KD patients during the
non-acute phase and the controls. For LEfSe, Kruskal–Wallis and
pairwiseWilcoxon tests are performed, followed by LDA to assess
the effect size of each differentially abundant taxon (Segata et al.,
2011). In this study, a p-value of<0.05 was considered significant
for both statistical methods. Bacteria with markedly increased
numbers were defined as those with an LDA score (log10) of over
2. Less than 0.01% of the total bacterial reads, corresponding
with ≤ 107 CFU/g feces, were omitted from further analysis
because of low and unreliable read counts, although significant
LDA scores were observed in LEfSe.
Isolation of Streptococcus spp. and Species
Determination Based on 16S-rRNA Gene
Cultivation of Streptococcus spp. was performed using
phenylethyl alcohol agar with 5% sheep blood or chocolate
agar under anaerobic conditions at 37◦C for 48 h. The bacterial
species present were determined by performing 16S-rRNA
gene sequencing using the bacterial forward primer Bac27F
(5′-AGAGTTTGGATCMTGGCTCAG-3′) and the universal
reverse primer Univ1492R (5′-CGGTTACCTTGTTACGACTT-
3′) (Eden et al., 1991). The obtained sequences were searched
against SILVA ribosomal RNA gene database to identify the
bacterial species (Quast et al., 2013).
Whole-Genome and Phylogenetic Analyses of
Identified Streptococcus spp.
A draft genome sequence was obtained by whole-genome
sequencing using MiSeq with a NEXTERA XT library
preparation kit (Illumina), followed by de novo assembly
with A5-MiSeq pipeline (Tritt et al., 2012). The resulting
scaffolds were annotated using RAST server (Aziz et al., 2008).
Maximum likelihood phylogenetic analysis of Streptococcus
16S-rDNA was performed using MEGA 6.0 with 1000 bootstrap
iterations (Tamura et al., 2013).
Minimum Inhibitory Concentration (MIC) Testing
MIC testing was performed using an Etest (bioMerieux, France)
on Muller-Hinton agar (Difco, Augsburg), according to CLSI
guidelines (CLSI, 2013).
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Results
KD Patients Included in Comparative
Metagenomic Analysis
This study evaluated 28KD patients (15 males and 13 females,
aged 1–114mo; median of 25mo). All of these patients were
enrolled within 4 days of the onset of illness, with day
1 defined as the first day of fever, and they all met the
diagnostic criteria for KD established by the American Heart
Association (Newburger et al., 2004). All of the KD patients
in the study received intravenous gamma globulin (2 g/kg) and
aspirin (30–50mg/kg/day). One male patient (patient P2) had
a persistent fever despite receiving these therapies and was
administered additional intravenous gamma globulin (1 g/kg)
and prednisolone sodium succinate (2mg/kg/day). This patient
had transient dilatation of the coronary artery, whereas the other
27 patients showed no evidence of cardiac abnormalities.
In this study, the time of admission was defined as the acute
phase, while 4–6 months after the onset of KD was considered
the non-acute phase. The profiles of the participants, including
the age, sex, concomitant symptoms and empirical antimicrobial
treatment received, are shown in Table 1.
Gut Microbiota Analysis Comparing the Acute
and Non-acute Phases in KD Patients
A total of 56 samples (28 samples each for the acute and
non-acute phases) were collected, including two samples from
each KD patient (Figure 1 and Table 1). Extracted DNA was
subjected to metagenomic sequencing using an Illumina GAIIx
next-generation DNA sequencer, and more than 10 million short
126-mer reads were obtained for each specimen. The short reads
were classified at the family level of bacteria, with a threshold
megaBLAST homology score of = 150. Principal component
analysis (PCA) was performed to elucidate the variations between
the acute and non-acute phases of KD. The results suggested
that the gut microbiota was more variable during the acute
phase than during the non-acute phase based on family-
level taxonomy (Figure 2A). PERMANOVA with 10,000 ×
permutations revealed significant dissimilarity of the bacterial
communities at the family level between the acute and non-acute
TABLE 1 | Kawasaki disease patient information.
KD patient Age Sex Concomitant symptoms Antimicrobial treatment during the acute phase
P1 3 y 11m M Vomiting, cough CMZ
P2 2 y 08m M Diarrhea, vomiting, cough CFPN-PI/CTX
P3 3 y 00m F Cough CMZ
P4 2 y 01m M Diarrhea CFPN-PI/CMZ
P5 1 y 03m F – AZM/CMZ
P6 2 y 03m F Diarrhea ABPC/CMZ
P7 3 y 04m F Diarrhea, vomiting CFPN-PI/CMZ
P8 0 y 08m F Diarrhea, vomiting ABPC-CVA/CMZ
P9 2 y 06m M Vomiting, abdominal pain CPDX-PR
P10 5 y 06m M Cough –
P11 7 y 05m F Diarrhea CAM
P12 2 y 10m F Neck stiffness –
P13 0 y 03m M – CCL
P14 2 y 02m M Rhinorrhea –
P15 1 y 06m F Cough CFPN-PI
P16 3 y 10m M – CDTR-PI
P17 0 y 10m F – –
P18 1 y 06m M – CFDN
P19 1 y 04m M Cough CDTR-PI/FOM
P20 2 y 00m F – –
P21 4 y 04m F Cough, diarrhea CFPN-PI/TFLX
P22 2 y 09m F – AMPC
P23 6 y 01m M – CFPN-PI
P24 3 y 00m M – CDTR-PI
P25 1 y 11m M – CFPN-PI/CAM
P26 9 y 06m F – CDTR-PI
P27 2 y 11m M – –
P28 0 y 04m M Vomiting CDTR-PI
y, year; m, month. M, male; F, female. ABPC, ampicillin; ABPC-CVA, ampicillin-clavulanic acid; AMPC, amoxicillin; AZM, azithromycin; CAM, clarithromycin; CCL, cefaclor; CDTR-PI,
cefditoren, pivoxil; CFDN, cefdinir; CFPN-PI, cefcapene pivoxil; CMZ, cefmetazole; CPDX-PR, cefpodoxime proxetil; CTX, cefotaxime; FOM, fosfomycin; TFLX, tosufloxacin.
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FIGURE 1 | The protocol for collection of clinical specimens.
FIGURE 2 | Principal component analysis of gut microbiota
compositions during the acute and non-acute phases of KD. (A)Relative
abundance was estimated at the family taxonomic level (megaBLAST
homology score threshold: ≥150). The arrows indicate the corresponding pair
for each patient for the acute and non-acute phases (n = 28). Some PCA plot
components were highlighted based on the indicated patient-related
information, group of non-antimicrobial treatment (B), diarrhea symptom (C),
and under two years old (D). To investigate the significance between the
tested groups, PERMANOVA with “ADONIS” was performed using 10,000×
permutations, in addition to the “bray” method, with R’s vegan package.
phases of KD (F-test = 3.7307, p = 0.0006) (Figure 2A).
The components were highlighted based on the antimicrobial
treatment, occurrence of diarrhea, and age group, indicating that
such variations during the acute phase might be associated with
patient-related factors. Further, the no antimicrobial treatment
group during the acute phase had was clustered in the lower
right area of the PCA plot (Figure 2B), whereas the diarrhea-
positive group during the acute phase exhibited a relatively
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scattered cluster in the PCA plot (Figure 2C); however, both
groups during the non-acute phase were clustered together at
the relative center of the plot (Figures 2B,C). The patients
in the antimicrobial treatment group did not always exhibit
diarrhea symptoms (8 diarrhea/22 antimicrobial treatment), and
PERMANOVA indicated no significant differences between the
two subject groups, suggesting that the gut microbiota was not
affected during the acute phase of KD, regardless of the presence
of antimicrobial treatment or diarrhea. The age factor showed
a possible association with gut microbiota composition because
the p-value was close to 0.05 when comparing subjects who were
less than 2 years of age with those who were over 2 years of age
(Figure 2D).
To determine the variations in gut microbiota composition
between the acute and non-acute phases, linear discriminant
analysis (LDA) coupled with effect size measurements (LEfSe)
was applied to determine which taxa were enriched in the
different groups according to metagenomic analysis (see detailed
parameters in Materials and Methods). LEfSe determines which
features (organisms, clades, operational taxonomic units, genes,
or functions) are most likely to explain differences between
classes by coupling standard tests for statistical significance
(between the acute and non-acute phases in this study) with
additional tests of biological consistency and effect relevance
(Segata et al., 2011). The obtained metagenomic reads were
classified at the genus level (Figure 3). Although LEfSe revealed
that the genera Rothia and Staphylococcus were the most
abundant during the acute phase, this dominance was not
observed in all of the patients (Figure 3). Regardless, relatively
increased numbers of Ruminococcus, Blautia, Faecalibacterium,
and Roseburia bacteria were observed during the non-acute
phase of KD (Figure 3), indicating that these genera was possibly
related to remission in KD patients.
The above genus classifications did not reveal which common
features were most likely to explain the differences between
the acute and non-acute phases in the tested KD patients
(n = 28). Because both pathogenic and non-pathogenic species
may be included within one bacterial genus, we speculated
that genus classifications would not reveal certain potential
pathogens involved in KD pathogenesis; thus, further taxonomic
FIGURE 3 | LEfSe at the genus level. Linear discriminant analysis
(LDA) combined with effect size measurements (LEfSe) revealed a list of
features that enable discrimination between the acute and non-acute
phases in the fecal samples. A p-value of <0.05 and a score ≥ 2.0
were considered significant in Kruskal–Wallis and pairwise Wilcoxon
tests, respectively. The horizontal straight line in the panel indicates the
group means, and the dotted line indicates the group medians. The
genus Ruminococcus was identified as the most predominant during the
non-acute phase, and the number of detected reads for all 28 patients
was plotted in bar form in the upper-right panel. The straight line
indicates the group means, and the dotted line indicates the group
medians. Less than 0.01% of the total bacterial reads, corresponding
to ≤ 107 CFU/g feces, were omitted from further analysis because of
low and unreliable read counts, although significant LDA scores were
observed (some bacteria are not shown due to insufficient amounts of
reads).
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classifications at the species level may allow for effective
detection of KD-related pathogens (Figure 4). Roseburia spp.
were relatively abundant during the non-acute phase and
could be identified at the genus level (Figure 3), whereas
Streptococcus spp. were predominantly identified during the
acute phase, suggesting that some Streptococcus spp., including
S. pneumoniae, S. oralis and other strains, are candidate KD-
related pathogens (Figure 4). Staphylococcus hyicus might have
been misidentified due to an insufficient amount of reads (less
than 0.01% of the population; <1000 of the assigned reads),
although the LDA score was significant.
Indeed, Streptococcus spp. were highly abundant in the gut
microbiotas of some of the KD patients; for example, 77%
of the bacterial reads of one KD patient (the acute phase in
P7) were from Streptococcus. However, the above-mentioned S.
pneumoniae and oralis species were not cultured from feces
during the acute phase of KD under conventional aerobic
cultivation on a phenylethyl alcohol agar plate with 5% sheep
blood in screening for Streptococcus spp., while anaerobic
cultivation on chocolate agar resulted in positive Streptococcus
colonies. In fact, fifty colonies of Streptococcus spp. were isolated
from P7-feces on chocolate agar under anaerobic conditions with
incubation at 37◦C for 16 h, and then 16S-rDNA sequencing was
performed to determine the bacterial species present. The results
suggested that seven Streptococcus spp. were unique isolates
(P7-Anaero4, P7-Anaero13, P7-Anaero24, P7-Anaero25, P7-
Anaero36, P7-Anaero39, and P7-Anaero45) (Figure 5C). Using
the draft genome sequences of seven P7-Streptococcus isolates,
including publicly available Streptococcus spp. complete genomes
(23 species), the metagenomic short reads of all 56 fecal samples
were classified at the species level by a megaBLAST search and
LEfSe. The results suggested that the amounts of the six P7-feces-
related Streptococcus isolates (P7-Anaero4, 13, 24, 36, 39, and 45,
but not P7-Anaero25) and the five detected Streptococcus spp. (S.
pneumonia, pseudopneumoniae, oralis, gordonii, and sanguinis)
were apparently increased during the acute phase in most of the
KD patients, including P7, whereas S. pasteurianus was increased
during the non-acute phase (Figures 5A,B). Intriguingly, the
top 4 most abundant positive isolates were P7-feces-related
Streptococcus spp. (P7-Anaero4, 45, 24, and 36) rather than
defined pathogenic Streptococcus species, and all positively
detected Streptococcus spp. were classified within a taxonomic
lineage closely related to S. oralis or pneumonia (Figure 5C). All
P7-feces-related Streptococcus isolates showed susceptibility to
most antimicrobial agents, including cephem, indicating that the
detection of abundant P7-feces-related isolates was most likely
not correlated with antimicrobial selection.
Based on species-level identification, the first and second
highest hits with identical BLAST scores constituted 17.9% of
all of the short reads, which were mostly homologous to rRNA
genes; thus, 82.1% of the short reads could be assigned to a
unique top hit. Although the obtained 126-mer short reads might
not have been sufficiently long for correct species assignments,
the BLAST search results suggested that the above-mentioned
P7-related Streptococcus groups were highly abundant during
the acute phase of KD, in contrast with other pathogenic
Streptococcus spp., such as S. pyogenes, dysgalactiae, mutans,
and pasteurianus. The significant detection of unique isolates
in KD patients implies a possible association of KD with
uncharacterized Streptococcus spp.
FIGURE 4 | LEfSe at the species level. LEfSe was performed as
described in Figure 3. Roseburia spp. were relatively abundant during the
non-acute phase and could be detected at the genus level (Figure 3),
whereas Streptococcus spp. were found to be predominant during the acute
phase. Less than 0.01% of the total bacterial reads, corresponding to ≤ 107
CFU/g feces, were omitted from further analysis because of low and
unreliable read counts, although significant LDA scores were observed
(Staphylococcus hyicus is not shown due to insufficient amounts of reads).
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FIGURE 5 | LEfSe of P7-related Streptococcus isolates performed
using Streptococcus genome database. (A) The type of
Streptococcus spp. markedly differed between the acute and non-acute
phases of KD. (B) The relative abundance of detected reads for the
patients (n = 28) was plotted for each Streptococcus spp. The
horizontal straight line indicates the group means, and the dotted line
indicates the group medians in the panel. (C) Maximum likelihood
phylogenetic analysis of Streptococcus 16S-rDNA. The Streptococcus
species in red and green are those with increased abundance during
the acute and non-acute phases of KD, respectively. The complete and
draft genome sequences used for the megaBLAST search are
highlighted with a light blue background.
Discussion
Various bacterial and viral agents have been reported to be
associated with KD pathogenesis (Johnson and Azimi, 1985;
Catalano-Pons et al., 2005; Wang et al., 2005; Joshi et al.,
2011), but these speculations have been controversial (Wang
et al., 2005). Colonization by normal microbiota variants have
been suggested to induce a dysregulation in the immune
systems of children with a pre-existing genetic defect in
immune maturation, leading to a hyperimmune reaction and
the development of KD (Lee et al., 2007). In this study, the
possible pathogens detected in the KD patients varied for each
individual patient; thus, every identified pathogen represented a
potential candidate. Regarding virus species, human adenovirus
(HAdV) species F was detected in one out of twenty-eight of the
patients, despite the absence of gastrointestinal manifestations
in that patient. Thus, HAdV was not commonly detected,
and no sequences from either other viruses or previously
reported pathogens were detected in any of the other KD
samples.
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Although the gut microbiota markedly differed at the genus
level between the acute and non-acute phases of KD (Figure 3),
we speculated that classification at the species level might be
appropriate for identifying disease-associated bacteria because
a genus includes species that have varying effects on human
health [e.g., S. pyogenes infections include acute rheumatic fever,
pharyngitis, impetigo and streptococcal toxic shock syndrome
(STSS); S. pneumoniae causes many types of pneumococcal
infections other than pneumonia; and S. mutans is a significant
contributor to tooth decay in the human oral cavity].
The findings of this study suggested that notable
Streptococcus spp. in the mitis group, including S. pneumonia,
pseudopneumoniae, mitis, oralis, gordonii, and sanguinis,
were highly abundant in the fecal samples during the acute
phase (Figures 4, 5); therefore, members of the mitis group
of Streptococci could be present in the bacterial flora of KD
patients. The mitis group comprises agents that contribute
to oral biofilms, dental plaques, and infective endocarditis,
disease processes that involve bacteria-bacteria and bacteria-host
interactions (Whatmore et al., 2000). To further elucidate
the association between Streptococcus spp. and KD in this
study, we isolated a unique Streptococcus spp. (Figure 5C) and
then performed whole-genome sequencing and a megaBLAST
homology search. The results revealed a significant abundance
of KD-derived Streptococcus isolates during the acute phase
of the disease (Figure 5). Intriguingly, a recent paper has
reported metagenomic analysis of the human gut microbiome
in liver cirrhosis patients, suggesting that oral commensals,
including Streptococcus spp., invade the gut in patients with liver
cirrhosis (Qin et al., 2014) and implying that uncharacterized
Streptococcus spp. could be potential biomarkers/pathogens for
diseases with unknown etiologies.
A SAg hypothesis for KD on the etiology remains
inconclusive, the involvement of single or multiple SAgs
on T-cell Vβ repertoires has been speculated for the KD
pathogenesis (Matsubara and Fukaya, 2007). A number of
studies have found primarily Vβ2 expansion (Abe et al., 1992;
Leung et al., 1995; Yoshioka et al., 1999) linking to the Vβ2
specific SAg such as toxic shock syndrome toxin-1 (TSST-1) and
SpeC (Nur-Ur Rahman et al., 2011), although there is no direct
evidence to suggest SAg involvement. STSS is significantly more
frequent in group A ß-hemolytic streptococcal (GAS) patients
than in groups B, C, and G streptococcal patients. GAS produces
a multitude of surface-bound and secreted virulence factors
causing resistance to phagocytosis, complement deposition,
antibody opsonization, and neutrophil killing mechanisms,
leading to overactive immune response and subverting host
innate immune defenses (Walker et al., 2014). Although the
isolation of SAg-positive Streptococcus from KD patients has
been reported (Nagata et al., 2009; Leahy et al., 2012), group A
ß-hemolytic streptococcal (GAS) might not contribute to the
pathogenesis of this disease because a rapid antigen detection
test (RADT) and proper antibiotic treatment prevents GAS
pharyngitis during the initial episodes of acute rheumatic fever
(Gerber et al., 2009). Because the KD patients in this study
(Table 1) were empirically treated with antibiotics during the
early stages of the disease, the results may reflect the effects of
the antibiotic therapy. To address this issue, a full comparison
of KD patients who have and have not received antibiotic
therapy should be performed in a large, controlled study. It is
also possible that antibiotic therapy has an adverse effect on
the pathogenesis of KD. Further investigation of the role of
Streptococcus spp. in the pathogenesis of KD is therefore merited.
Our previous metagenomic approach indicated that
Streptococcus spp. were present in the lymph node specimen of
one KD patient, highlighting the possible role of these bacteria in
KD (Katano et al., 2012). To identify the SAg homologs, all short
reads and coding sequences of the 7 isolates (P7-Anaero4, 13,
24, 25, 36, 39, and 45) were subjected to a PSI-BLAST homology
search against “superantigen, staphylococcal/streptococcal
toxin, bacterial (IPR013307)” orthologous proteins; however, no
significant match has been found thus far (data not shown). In
addition, some sequences from each sample were classified as
“Not assigned” in metagenomic analysis, and new pathogenic
agents remain to be characterized for some of these unidentified
sequences.
The gut microbiota in the non-acute phase of KD (the distant
phase) was similar in each patient, and the genera Ruminococcus,
Roseburia and Faecalibacterium were predominant (Figure 3).
In previous reports, an observed elevation in LPS-binding
neutrophils or plasma proteins has been observed, suggesting
that LPS infusion followed by disruption in intestinal mucosal
barrier function might be involved in the pathogenesis of this
disease (Takeshita et al., 1999, 2002b); therefore, a well-balanced
commensal gut microbiota contributes to the mucosal barrier
function of the intestine. Prebiotics, probiotics, and combination
synbiotics modulate the balance of the intestinal microbiota and
may help to prevent the onset of KD to improve patient prognosis
(Bosscher et al., 2009).
The microbiota of KD patients was comprehensively analyzed
in this study. Our findings suggest that markedly increased
amounts of Streptococcus spp. are present in the gut microbiotas
of acute-phase KD patients and that this difference in microbiota
composition might be related to KD pathogenesis.
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